urse Decision Making and the Management of Vasoactive Medications in the Intensive Care Unit

Eastern Health0 个研究点目标入组 74 人开始时间: 2019年7月11日最近更新: 2019年7月22日

适应症

试验速览

暂无简介。

•Nurse inclusion criteria:
•Nurses who are employed on a permanent full time or part time basis by the intensive care unit
•Patient inclusion criteria:
•Patients who have been admitted to the ICU
•Patient has been allocated a nurse who has previously provided written consent to participate in either video or empirical data collection
•Patients who are assessed by the ICU medical team as likely to need vasoactive support for the next 12 hours
•Patients who have a functional arterial line in situ and
•Patients who have a central venous catheter is in situ or insertion is imminent

•Nurse exclusion criteria:
•Nurses who have previously participated in this study
•Nurses who do not have direct patient care responsibilities
•Patient exclusion criteria:
•Patients who are aged less than 18 years
•Patients who will be out of the intensive care unit (ICU) for (i.e. for transport to Medical Imaging or
•Operating Theatre) for the observation period
•Patients who are assessed by the ICU treating team as unlikely to need vasoactive support for the four-hour data collection period.
•Patients who have been transitioned to palliative care
•Patients or their Medical Treatment Decision Makers are visibly distressed
•The medical team or bedside nurse considers that it is an inappropriate time to approach the patient or Medical Treatment Decision Maker with information about the study.

发起方